期刊文献+

冠状动脉内放射治疗对支架内再狭窄的作用 被引量:6

The effect of intracoronary brachytherapy after coronary angioplasty on in stent restenosis
原文传递
导出
摘要 目的 研究应用β射线 (90 Sr/90 y)进行冠状动脉内放射治疗对国人支架内再狭窄的作用。方法 自 1 999年 1 2月至 2 0 0 2年 1月 ,我院对 5 3例患者 [男 4 9例 ,女 4例 ,平均年龄 (5 3 2± 9 8)岁 ]5 5处支架内再狭窄病变 (支架直径≥ 2 5mm ,1 0mm≤病变长度≤ 30mm) ,在球囊 (1 0处病变用普通球囊 ,4 5处病变用切割球囊 )满意扩张后 ,应用Beta Cath系统 (Novoste)进行冠状动脉内放射治疗。放射源长度 4 0mm。术后 8个月随访冠状动脉造影 ,用MEDCONViewer软件包进行定量冠状动脉造影 (QCA)分析。结果  5 3例患者 5 5处支架内再狭窄病变均被满意扩张 ,冠状动脉内放射治疗全部成功 ,术中并发冠状动脉痉挛 1例 (1 8%) ,无其他并发症。全部患者随访期中无死亡 ,随访≥ 8个月 33例患者中 1例 (3 0 %)发生非Q波心肌梗死 ,6例 (1 8 2 %)进行靶血管重建术。该 33例患者中 2 9例(87 9%) 30处病变进行了随访冠状动脉造影 ,再狭窄率在支架段为 1 0 0 %(3/30 ) ,分析段为 2 3 3 %(7/30 )。最小管径直径术前为 (0 41± 0 2 2 )mm ,术后即刻为 (1 99± 0 42 )mm ,8个月随访时为 (1 73± 0 82 )mm ,平均病变长度为 (2 3 3± 5 4)mm。全部患者无晚期血栓形成、假性动脉瘤及冠状动脉瘤发生。结论 应用90 Objective To evaluate the effect of intracoronary brachytherapy using 90 Sr/ 90 y after balloon angioplasty on in stent restenosis in Chinese patients Methods Fifty five lesions with in stent restenosis (stent diameter ≥2 5 mm, 10 mm ≤ lesion length ≤30 mm) in 53 patients, male 49, female 4, with mean age of (53 2±9 8) years, were treated using Beta Cath system (Novoste) with 40 mm of source train after balloon angioplasty, using regular balloon in 10 lesions and cutting balloon in 45 lesions, in this institution from December 1999 to January 2002 Follow up angiography was performed after 8 months of brachytherapy Quantitative coronary angiography (QCA) was performed by MEDCON Viewer QCA software package Results The procedure of balloon angioplasty followed by brachytherapy were successful in all 55 lesions (100%) Refractory coronary spasm developed in 1 (1 8%) case No other complications occurred During follow up period no death occurred Among the 33 cases who were followed more than 8 months non Q myocardial infarction developed in 1 (3 0%) patients, target vessel revascularization in 6 (18 2%) cases Follow up angiography was performed in 30 lesions of the 29 (87 9%) cases, which revealed that binary restenosis, defined as diameter stenosis ≥50%, was 10 0% (3/30) in stent segments and 23 3% (7/30) in analysis segments The mininum luminal diameter was (0 41±0 22) mm before angioplasty, (1 99±0 42) mm immediately after angioplasty and (1 73±0 82) mm at 8 months follow up The mean lesion length was (23 3±5 4) mm No coronary aneurysm and pseudoaneurysm were detected during follow up angiography Conclusion The brachytherapy using 90 Sr/ 90 y after balloon angioplasty is safe and feasible for in stent restenosis in Chinese patients In this group of patients the restenosis rate is similar to that reported in large scale clinical trials The results suggest that brachytherapy should be performed if the lesion length of in stent restenosis was longer than 10 mm
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2002年第5期259-262,共4页 Chinese Journal of Cardiology
关键词 冠状动脉疾病 血管成形术 近距离放射疗法 支架内再狭窄 Coronary disease Angioplasty Stent Brachytherapy
  • 相关文献

参考文献10

  • 1vom Dahl J,Dietz U,Haager PK,et al.On behalf of the ARTIST Investigators.Angioplasty versus rotational atherectomy for treatment of diffuse in-stent restenosis: clinical and angiographic results from a randomized multicenter trial[].Journal of the American College of Cardiology.2000
  • 2Waksman R,White RL,Chen RC,et al.Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis[].Circulation.2000
  • 3Popma J.Late Clinical and angiographic outcomes after use of 90 Sr/90y beta radiation for the treatment of in-stent restenosis: results from the 90 Sr Treatment of Angiographic Restenosis (START) Trial[].Journal of the American College of Cardiology.2000
  • 4Waksman R,Rhargava B,White RL,et al.Intracoronary radiation for patients with refractory in-stent restenosis.An analysis from the WRISTCrossover Trial. Washington Radiation for In-Stent Restenosis Trial[].Cardiovascular Radiation Medicine.1999
  • 5Condado JA,Waksman R,Gurdiel O,et al.Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans[].Circulation.1997
  • 6Leon MB,Teirstein PS,Moses JW,et al.Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting[].The New England Journal of Medicine.2001
  • 7Raizner AE,Oesterle SN,Waksman R,et al.Inhibition of restenosis with beta-emitting radiotherapy: report of the Proliferation Reduction with Vascular Energy Trial (PREVENT)[].Circulation.2000
  • 8Mehran R,Dangas G,Mintz GS,et al.Treatment of in-stent restenosis with excimer laser coronary angioplasty versus rotational atherectomy:comparative mechanisms and results[].Circulation.2000
  • 9Kim HS,Waksman R,Cottin Y,et al.Edge stenosis and geographical miss following intracoronary gamma radiation therapy for in-stent restenosis[].Journal of the American College of Cardiology.2001
  • 10Malhotra S,Teirstein PS.The SCRIPPS trial - - catheter-based radiotherapy to inhibit coronary restenosis[].Journal of Invasive Cardiology.2000

同被引文献24

  • 1Hong MK, Mehran GS, Mintz GS, et al. Restenosis after coronary angioplasty. Curr Probl Cardiol, 1997,22:7-27.
  • 2Eric E, Lukas K, Jean-Jacques G. Stent for intracoronary placement: Current status and future directions. J Am Coll Cardiol, 1996,27:757-765.
  • 3vom Dahl J, Dietz U, Haager PK,et al. Rotational atherectomy does not reduce recurrent in-stent restenosis: results of the angioplasty versus rotational atherectomy for treatment of diffuse instent restenosis trial (ARTIST). Circulation, 2002 , 105 ( 5 ) :583-588.
  • 4Mehran R, Dangas G, Mintz GS, et al. Treatment of in-stent restenosis with excimer laser coronary angioplasty versus rotational atherectomy: comparative mechanisms and results. Circulation,2000, 101 (21) : 2484-2489.
  • 5PopmaJJ, Suntharalingam M, Lansky A J, et al. Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis. Circulation, 2002 ,106(9) :1090-1096.
  • 6Grube E, Silber S, Hauptmann KE, et al. TAXUS 1 :Six-and twelve-months results from a randomized double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions.Circulation, 2003, 107( 1 ): 38-42.
  • 7Stone GW, Ellis SG, Cox DA, et al. One-year clinical results with the slow-release polymer-based, paclitaxel-eluting TAXUS stent. The TAXUS-1V trial. Circulation, 2004, 109(16) : 1942-1947.
  • 8Holmes DR Jr, Leon MB, Moses JW, et al. Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restonsis. Circulation, 2004, 109 ( 5 ) :634-640.
  • 9Sousa JE, Costa MA, Abizaid A, et al. Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents. Circulation,2005,111(18) :2326-2329.
  • 10Yah BP, Ajani AE, Waksman R. Drug-eluting stents for the treatment of in-stent restenosis: a clinical review. Cardiovasc Revasc Med ,2005,6(1):38-43.

引证文献6

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部